ACTIVE

CFA Pharma

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

6,7 k €

-74.7% YoY

Gross margin

52,2 k €

-1.1% YoY

Equity

153,9 k €

+0.5% YoY

What does CFA Pharma do?

CFA Pharma is a Private limited company incorporated in 1986. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Ieper.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0428.715.650

Incorporation

24/03/1986

Legal form

Private limited company

Registered office

Blauwepoortstraat 1
8902 Ieper · FlandreSee on map

Contributed capital

28 000,00 €

Latest accounts

31/12/2025

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores 52310Warehousing and support activities for transportation

Signals

ProfitableLow riskGood liquidityPositive cashflowPositive EBITDA

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 20 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Gross margin	52,2 k €	-1.1%	52,7 k €	+147%	21,4 k €	-57.1%	49,9 k €	-2.5%	51,1 k €	-2.4%	52,4 k €	+2.5%	51,1 k €	+6.5%	48 k €	+77.5%	27 k €	-6.9%	29 k €	+4.3%	27,8 k €	-0.3%	27,9 k €	+17.5%	23,8 k €	-14.5%	27,8 k €	+2.9%	27 k €	+2.4%	26,4 k €	+0.5%	26,3 k €	+4.5%	25,1 k €	+3.1%	24,4 k €	+17.8%	20,7 k €
EBITDA	49,3 k €	-4.5%	51,6 k €	+170%	19,1 k €	-60.9%	48,9 k €	-2.6%	50,2 k €	-2.5%	51,4 k €	+2.5%	50,2 k €	+6.6%	47,1 k €	+77.1%	26,6 k €	-7.0%	28,6 k €	+4.4%	27,4 k €	-0.3%	27,5 k €	+18.3%	23,2 k €	-15.1%	27,4 k €	+2.9%	26,6 k €	+2.7%	25,9 k €	+0.3%	25,8 k €	+4.6%	24,7 k €	+3.1%	24 k €	+18.1%	20,3 k €
Operating result	21,6 k €	-35.7%	33,6 k €	+2986%	1,1 k €	-97.1%	37,1 k €	+0.0%	37,1 k €	+0.5%	36,9 k €	+8.4%	34 k €	+110%	16,2 k €	+184%	5,7 k €	-77.7%	25,4 k €	+5.0%	24,2 k €	-0.4%	24,3 k €	+8.7%	22,4 k €	-18.3%	27,4 k €	+2.9%	26,6 k €	+2.7%	25,9 k €	+0.3%	25,8 k €	+4.6%	24,7 k €	+3.1%	24 k €	+19.3%	20,1 k €
Net result	6,7 k €	-74.7%	26,7 k €	+4032%	645,1 €	-97.6%	27,2 k €	+10.5%	24,6 k €	+2.7%	24 k €	+17.9%	20,3 k €	+132%	8,8 k €	+140%	3,7 k €	-78.7%	17,1 k €	-1.5%	17,4 k €	-10.7%	19,4 k €	-2.8%	20 k €	-15.4%	23,7 k €	+48.8%	15,9 k €	-28.1%	22,1 k €	-8.5%	24,2 k €	+6.5%	22,7 k €	+1.5%	22,3 k €	+1.8%	21,9 k €
Balance sheet
Equity	153,9 k €	+0.5%	153,2 k €	+12.2%	136,5 k €	-2.2%	139,5 k €	+7.8%	129,4 k €	-10.0%	143,8 k €	+3.3%	139,2 k €	+17.1%	118,9 k €	+8.0%	110,1 k €	-68.4%	348,6 k €	+5.2%	331,5 k €	+5.5%	314,2 k €	+6.6%	294,7 k €	-2.3%	301,5 k €	+8.5%	277,9 k €	+6.1%	262 k €	+9.2%	239,9 k €	+11.2%	215,8 k €	+11.7%	193,1 k €	+13.1%	170,7 k €
Total assets	525,3 k €	+34.8%	389,7 k €	-17.4%	471,6 k €	+90.9%	247 k €	-4.9%	259,8 k €	-13.5%	300,3 k €	-3.5%	311 k €	+2.6%	303,1 k €	-45.3%	554,5 k €	+56.8%	353,7 k €	+4.2%	339,4 k €	+6.6%	318,2 k €	+2.3%	311 k €	-1.5%	315,8 k €	+10.9%	284,7 k €	+5.7%	269,5 k €	+9.0%	247,1 k €	+11.2%	222,1 k €	+11.3%	199,5 k €	+12.6%	177,2 k €
Cash	6,1 k €	-20.5%	7,7 k €	-93.8%	123,5 k €	+188%	43 k €	-4.8%	45,1 k €	-38.2%	73 k €	+11.6%	65,3 k €	+85.3%	35,3 k €	-86.4%	259 k €	-11.5%	292,5 k €	+6.4%	275 k €	+180%	98,3 k €	-1.5%	99,8 k €	-6.9%	107,2 k €	+14.9%	93,3 k €	+107%	45,1 k €	+210%	14,5 k €	-22.9%	18,8 k €	+1.9%	18,5 k €	-79.2%	89 k €
Debts	371,3 k €	+57.0%	236,6 k €	-29.4%	335,1 k €	+212%	107,5 k €	-17.5%	130,3 k €	-16.7%	156,5 k €	-8.9%	171,8 k €	-6.7%	184,2 k €	-58.5%	444,4 k €	+8695%	5,1 k €	-35.5%	7,8 k €	+123%	3,5 k €	-76.9%	15,2 k €	+12.4%	13,6 k €	+111%	6,4 k €	-8.8%	7 k €	+3.8%	6,8 k €	+12.9%	6 k €	-0.6%	6 k €	-1.1%	6,1 k €

Estimate

Indicative valuation

As an indication, this company is worth

between 0 € and 100 k€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 14 ended

Active mandates

Anne-Sophie BONTE

Director · since 08 janvier 2024

Active

MILDRO

Director · since 08 janvier 2024 · 0429.568.062

Represented by VERBEKE Alexandre

Active

Ended mandates

Geneviève Bonte Anne-Sophie

Director · since 08 janvier 2024

Ended

MILDRO

Director · since 08 janvier 2024 · 0429.568.062

Represented by VERBEKE ALEXANDRE

Ended

Cecile Sampers

Director

Ended

Cecile Sampers

Manager

Ended

At this address

Other companies at this address

Company	CBE no.
Apotheek Bonte● Active	0804.144.351
MILDRO● Active	0429.568.062

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Micro model	Micro model	Micro model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	31/08/2026	24/03/2026	31/08/2024	18/07/2023	04/07/2022	07/07/2021
General meeting	11/07/2026	21/06/2025	15/06/2024	17/06/2023	18/06/2022	19/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

20 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Micro model	31/12/2025	11/07/2026	31/08/2026	Dutch	PDF
Micro model	31/12/2024	21/06/2025	24/03/2026	Dutch	PDF
Micro model	31/12/2023	15/06/2024	31/08/2024	Dutch	PDF
Abridged model	31/12/2022	17/06/2023	18/07/2023	Dutch	PDF
Abridged model	31/12/2021	18/06/2022	04/07/2022	Dutch	PDF
Abridged model	31/12/2020	19/06/2021	07/07/2021	Dutch	PDF
Abridged model	31/12/2019	20/06/2020	01/07/2020	Dutch	PDF
Abridged model	31/12/2018	15/06/2019	04/07/2019	Dutch	PDF
Abridged model	31/12/2017	16/06/2018	12/07/2018	Dutch	PDF
Abridged model	31/12/2016	17/06/2017	26/06/2017	Dutch	PDF
Abridged model	31/12/2015	18/06/2016	24/06/2016	Dutch	PDF
Abridged model	31/12/2014	20/06/2015	22/06/2015	Dutch	PDF
Abridged model	31/12/2013	21/06/2014	23/06/2014	Dutch	PDF
Abridged model	31/12/2012	08/06/2013	27/06/2013	Dutch	PDF
Abridged model	31/12/2011	16/06/2012	25/06/2012	Dutch	PDF
Abridged model	31/12/2010	18/06/2011	04/07/2011	Dutch	PDF
Abridged model	31/12/2009	12/06/2010	14/06/2010	Dutch	PDF
Abridged model	31/12/2008	13/06/2009	22/06/2009	Dutch	PDF
Abridged model	31/12/2007	14/06/2008	14/07/2008	Dutch	PDF
Abridged model	31/12/2006	09/06/2007	14/06/2007	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 0 € and 100 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 14 ended

Active mandates

Anne-Sophie BONTE

Director · since 08 janvier 2024

Active

MILDRO

Director · since 08 janvier 2024 · 0429.568.062

Represented by VERBEKE Alexandre

Active

Ended mandates

Geneviève Bonte Anne-Sophie

Director · since 08 janvier 2024

Ended

MILDRO

Director · since 08 janvier 2024 · 0429.568.062

Represented by VERBEKE ALEXANDRE

Ended

Cecile Sampers

Director

Ended

Cecile Sampers

Manager

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Other03/04/2024
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - BENAMING - DOEL
PDF
Mandates12/02/2024
MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
PDF
Registered office03/04/2019
MAATSCHAPPELIJKE ZETEL
PDF
Capital / shares22/01/2018
KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Capital / shares03/01/2014
KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Mandates29/02/2008
ONTSLAGEN - BENOEMINGEN
PDF
Mandates24/12/2003
ONTSLAGEN - BENOEMINGEN
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 20256,7 k €↓
2024
Annual accounts 202426,7 k €↑
2023
Annual accounts 2023645,1 €↓
2023
Name changeCFA Pharma
2022
Annual accounts 202227,2 k €↑
2021
Annual accounts 202124,6 k €↑
2021
Name changeAPOTHEEK SAMPERS
2020
Annual accounts 202024 k €↑
2019
Annual accounts 201920,3 k €↑
2018
Annual accounts 20188,8 k €↑
2017
Annual accounts 20173,7 k €↓
2016
Annual accounts 201617,1 k €↓
2015
Annual accounts 201517,4 k €↓
2014
Annual accounts 201419,4 k €↓
2013
Annual accounts 201320 k €↓
2012
Annual accounts 201223,7 k €↑
2011
Annual accounts 201115,9 k €↓
2010
Annual accounts 201022,1 k €↓
2009
Annual accounts 200924,2 k €↑
2008
Annual accounts 200822,7 k €↑
2007
Annual accounts 200722,3 k €↑
2006
Annual accounts 200621,9 k €
24/03/1986
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

CFA Pharma

Overview

What does CFA Pharma do?

Trend over 20 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline